Horizon Discovery Ltd. gene/cell therapy, functional genomics news

Horizon joined the 4D Cell Fate consortium, which is researching the regulation of stem cell reprogramming and differentiation at the epigenetic level. Horizon will use its GENESIS recombinant adeno-associated virus (rAAV) gene editing technology to generate cell lines with endogenous pathway reporter genes and labeled epigenetic target proteins. ...